Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib in NSCLC with Brain Metastases
NCT02132598Phase 2Terminated
- Start
- Dec 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in non-small cell lung cancer (NSCLC). Started Dec 2015; status: terminated.
02
Drugs
cabozantinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02132598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132598.